Literature DB >> 15843916

Is disturbance of consciousness an important feature of ICU delirium?

Nicolas Bergeron, Yoanna Skrobik, Marc-Jacques Dubois.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15843916     DOI： 10.1007/s00134-005-2642-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  3 in total

1.  Confusion assessment method in the diagnostics of delirium among aged hospital patients: would it serve better in screening than as a diagnostic instrument?

Authors:  J V Laurila; K H Pitkala; T E Strandberg; R S Tilvis
Journal:  Int J Geriatr Psychiatry       Date:  2002-12       Impact factor: 3.485

2.  Intensive Care Delirium Screening Checklist: evaluation of a new screening tool.

Authors:  N Bergeron; M J Dubois; M Dumont; S Dial; Y Skrobik
Journal:  Intensive Care Med       Date:  2001-05       Impact factor: 17.440

3.  Consciousness monitoring in ventilated patients: bispectral EEG monitors arousal not delirium.

Authors:  E Wesley Ely; Brenda Truman; Donna J Manzi; Jeffrey C Sigl; Ayumi Shintani; Gordon R Bernard
Journal:  Intensive Care Med       Date:  2004-05-04       Impact factor: 17.440
  3 in total
  3 in total

1.  The accurate recognition of delirium in the ICU: the emperor's new clothes?

Authors:  John W Devlin; Gilles L Fraser; Aaron M Joffe; Richard R Riker; Yoanna Skrobik
Journal:  Intensive Care Med       Date:  2013-10-11       Impact factor: 17.440

Review 2.  Delirium assessment in the critically ill.

Authors:  John W Devlin; Jeffrey J Fong; Gilles L Fraser; Richard R Riker
Journal:  Intensive Care Med       Date:  2007-03-31       Impact factor: 17.440

3.  Pediatric delirium in critical illness: phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unit.

Authors:  Jan N M Schieveld; Piet L J M Leroy; Jim van Os; Joost Nicolai; Gijs D Vos; Albert F G Leentjens
Journal:  Intensive Care Med       Date:  2007-04-25       Impact factor: 17.440
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.